Clive Tonna. Dorianne Grech. Environmental Health Policy Coordination

Similar documents
REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

I confirm that I read the note and followed the instructions therein

REPORTING INSTRUMENT

REPORTING INSTRUMENT

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

REPORTING INSTRUMENT

REPORTING INSTRUMENT

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

Country profile. Myanmar

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

Country profile. Lebanon

Country profile. Nepal

1. Origin of the report

Country profile. Timor-Leste

REPORTING INSTRUMENT

REPORTING INSTRUMENT

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL 1. ORIGIN OF THE REPORT

Country profile. Poland

I confirm that I read the note and followed the instructions therein

Country profile. Trinidad and Tobago

Country profile. Angola

Country profile. New Zealand

Country profile. Cuba

PHASE 2 (GROUP 2 QUESTIONS) OF THE REPORTING INSTRUMENT UNDER THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

Country profile. Russian Federation. WHO Framework Convention on Tobacco Control (WHO FCTC) status

Country profile. Senegal

Country profile. Bahrain. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 20 March 2007

Country profile. Hungary

Country profile. Turkmenistan. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 13 May 2011

Country profile. Republic of Moldova

Bosnia and Herzegovina

Country profile. Austria

United Kingdom of Great Britain and Northern Ireland

Lao People's Democratic Republic

Country profile. Egypt

Country profile. Italy

Country profile. Gambia

Country profile. Sweden

Country profile. Ukraine

Country profile. Gambia. Note: Where no data were available, " " shows in the table. Where data were not required, " " shows in the table.

Country profile. Yemen

Country profile. Brazil

Country profile. Chad

Country profile. Norway

REVISED REPORTING INSTRUMENT 1

1. Origin of the report

Country profile. Guinea

Country profile. Colombia. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent) 10 April 2008

Report card on the WHO Framework Convention on Tobacco Control

South Africa. Report card on the WHO Framework Convention on Tobacco Control. 18 July Contents. Introduction

Iran (Islamic Republic of)

Country profile. Morocco

Country profile. Canada

Country profile. Indonesia. WHO Framework Convention on Tobacco Control (WHO FCTC) status. Date of ratification (or legal equivalent)

Country profile. Switzerland

1. Origin of the report

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

REPORTING INSTRUMENT

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

Uganda. Report card on the WHO Framework Convention on Tobacco Control. 18 September Contents. Introduction

Mali. Report card on the WHO Framework Convention on Tobacco Control. 17 January Contents. Introduction. Mali entry into force of the WHO FCTC

I confirm that I read the note and followed the instructions therein

Burkina Faso. Report card on the WHO Framework Convention on Tobacco Control. 29 October Contents. Introduction

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

I confirm that I read the note and followed the instructions therein

WHO Framework Convention on Tobacco Control

Zimbabwe. Zimbabwe has not signed and has not ratified the WHO FCTC. Report card on the WHO Framework Convention on Tobacco Control.

APPENDIX V: COUNTRY PROFILES

ACTION PLAN. Intergovernmental Coordinating Body, Ministry of Finance. Intergovernmental Coordinating Body, Ministry of Finance

LAW OF MONGOLIA. 01 July, Ulaanbaatar, Mongolia LAW ON TOBACCO CONTROL CHAPTER ONE GENERAL PROVISIONS

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

REPORTING INSTRUMENT. Vietnam

1. Origin of the report

I confirm that I read the note and followed the instructions therein

REPORTING INSTRUMENT OF THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL

Tobacco Free Ireland Action Plan

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT

LAW OF MONGOLIA. 01 July 2005 Ulaanbaatar city ON TOBACCO CONTROL. (revised) CHAPTER ONE GENERAL PROVISIONS

Guidelines for implementation of Article 14

Ministerial Round Table: Accelerating implementation of WHO FCTC in SEAR

EXECUTIVE SUMMARY. 1 P age

Challenges ahead to reach the goal set up in Tobacco End Game 2025

Government Gazette REPUBLIC OF SOUTH AFRICA

TOBACCO INDUSTRY MONITORING TOOL

- Decree nº (January 2 nd, 2006) Promulgates the Framework Convention on Tobacco Control

Transcription:

1. ORIGIN OF THE REPORT 1.1 NAME OF CONTRACTING PARTY MALTA 1.2 Information on national contact responsible for preparation of the report: Name and title of contact officer Clive Tonna Full name of institution Mailing address Director (Environmental Health) Environmental Health Directorate Health Inspectorate Services Continental Business Centre Old Railway Track Santa Venera SVR 9018 MALTA Telephone number 00356-21320413 Fax number 00356-21344767 E-mail clive.j.tonna @gov.mt 1.3 Signature of government official submitting the report: Name and title of officer Dorianne Grech Full name of institution Mailing address Environmental Health Policy Coordination Unit Environmental Health Directorate Health Inspectorate Services Continental Business Centre Old Railway Track Santa Venera SVR 9018 MALTA Telephone number 00356-2133733 Fax number E-mail Web page dorianne.grech@gov.mt n/a 1.4 Period of reporting 2014 1.5 Date the report was submitted March 2014 1

2. TOBACCO CONSUMPTION AND RELATED HEALTH, SOCIAL AND ECONOMIC INDICATORS (with reference to Articles 19.2(a), 20.2, 20.3(a), 20.4(c) as well as Articles 6.2(a), 6.2(b), 6.3, 15.4, 15.5 and 17 as referred to in the respective subsections) 2.1 PREVALENCE OF TOBACCO USE 2.1 PREVALENCE OF TOBACCO USE 2.1.1 Smoking prevalence in the adult population (all) (Please provide prevalence data for total adult population, and identify the age considered, e.g. 15 years old and over, 18-64 years; see 2.1.1.2) MALES Prevalence () (please include all smoking tobacco products in prevalence data) Current smokers 31 Average number of the mostconsumed smoking tobacco product used per day Daily smokers 25.6 15 manufactured cigarettes Occasional smokers 5.4 Former smokers 22.2 Never smokers 46.9 FEMALES Current smokers 21.4 Daily smokers 15.8 13 manufactured cigarettes Occasional smokers 5.5 Former smokers 10.2 Never smokers 68.5 TOTAL (males and females) Current smokers 25.7 Daily smokers 20.3 14 manufactured cigarettes Occasional smokers 5.4 Former smokers 15.7 Never smokers 58.6 2

2.1.1.1 Please indicate the smoking tobacco products included in calculating prevalence for question 2.1.1: Manufactured cigarettes, hand rolled cigarettes, cigars, pipefuls of tobacco. 2.1.1.2 Please indicate the age range to which the data used to answer question 2.1.1 refer: 15 years and over (Maltese resident population) 2.1.1.3 Please indicate the year and source of the data used to answer question 2.1.1: 2008 (European Health Interview Survey) 2.1.1.4 Please provide the definitions of current smoker, daily smoker, occasional smoker, former smoker and never smoker used in this report. Current Smoker - Respondents smoking daily or occasionally at time of interview, Occasional Smoker - Respondents who do not smoke daily but smoke occasionally, Former Smoker - Respondents who presently do not smoke but smoked daily or almost daily for a period of 1 year or more, Never Smoker - Respondents who currently do not smoke and never smoked for a year or more. 2.1.1.5 Please provide a brief explanation of the trend in smoking prevalence in the adult population in the past two years or since submission of your last report. new data available since last report. 3

2.1.2 Smoking prevalence in the adult population (by age groups) (If data are available, please provide prevalence data by age group, and identify the age group considered, preferably by 10-year categories, e.g. 25-34, 35-44 years) MALES Age group (adults) Prevalence () (please include all smoking tobacco products in prevalence data) Current smokers 1 Add age group 15-24 32.3 25-34 39.2 35 44 33.2 45-54 36.6 55-64 26 65 74 23.6 75+ 13.7 FEMALES Current smokers 1 Add age group 15-24 26.2 25-34 29.3 35 44 28.6 45-54 27.5 55-64 15.9 65 74 7.5 75+ 2.4 TOTAL (males and females) Current smokers 1 Add age group 15-24 29.2 25-34 33.8 35 44 30.7 45-54 31.8 55-64 20.6 1 Please provide here data on either all current smokers or daily smokers only, whichever is available. 4

65 74 15.1 75+ 7 5

2.1.2.1 Please indicate the smoking tobacco products included in calculating prevalence for question 2.1.2: Manufactured cigarettes, hand rolled cigarettes, cigars, pipefuls of tobacco. 2.1.2.2 Please indicate the year and source of the data used to answer question 2.1.2: 2008 (European Health Interview Survey) 2.1.2.3 Please provide a brief explanation of the trend in current smoking prevalence by age group in the past two years or since submission of your last report, if data are available. new data available since last report. 6

2.1.3 Prevalence of smokeless tobacco use in the adult population (all) (Please provide prevalence data for total adult population, and identify the age considered in 2.1.3.2, e.g. 15 years old and over, 18 64 years; see 2.1.3.2) MALES Prevalence () (please include all smokeless tobacco products in prevalence data) Current users Daily users Occasional users Former users Never users FEMALES Current users Daily users Occasional users Former users Never users TOTAL (males and females) Current users Daily users Occasional users Former users Never users 7

2.1.3.1 Please indicate the smokeless tobacco products included in calculating prevalence for question 2.1.3: 2.1.3.2 Please indicate the age range to which the data used to answer question 2.1.3 refer: 2.1.3.3 Please indicate the year and source of the data used to answer question 2.1.3: 2.1.3.4 Please provide the definitions of current user, daily user, occasional user, former user and never user (of smokeless tobacco products) used in this report in the space below. 2.1.3.5 Please provide a brief explanation of the trend in smokeless tobacco use in the adult population in the past two years or since submission of your last report. data is currently available. 8

2.1.4 Prevalence of smokeless tobacco use in the adult population (current users) by age group (If data are available, please provide prevalence data by age group, and identify the age group considered, preferably by 10-year categories, e.g. 25-34, 35-44 years) MALES Age group (adults) Prevalence () (please include all smokeless tobacco products in prevalence data) Current users 2 Add age group FEMALES Current users 2 Add age group TOTAL (males and females) Current users 2 Add age group 2 Please provide data on either all current users or daily users only, whichever is available. 9

2.1.4.1 Please indicate the smokeless tobacco products included in the answer to question 2.1.4: 2.1.4.2 Please indicate the year and source of the data used to answer question 2.1.4: 2.1.4.3 Please provide a brief explanation of the trend in current use of smokeless tobacco by adult age groups in the past two years or since submission of your last report. 2.1.5 Tobacco use by ethnic group(s) Current users 3 Add ethnic group Ethnic group(s) Prevalence () (please include all smoking or smokeless tobacco products in prevalence data) Males Females Total (males and females) 2.1.5.1 Please indicate the tobacco products included in the answer to question 2.1.5: 2.1.5.2 Please indicate the age range to which the data used to answer question 2.1.5 refer: 2.1.5.3 Please indicate the year and source of the data used to answer question 2.1.5: data is available. 3 Please provide data on either all current users or daily users only, whichever is available. 10

2.1.6 Tobacco use by young persons Boys Age range Prevalence () (please include all smoking or smokeless tobacco products in prevalence data) Smoking tobacco Smokeless tobacco Other tobacco (e.g. water pipe) Current users 4 Add youth group 15 16* 23 11 5.7 13 5.3 15 8.6 Girls Current users 4 Add youth group 15-16 * 20 11 0.6 13 3.4 TOTAL (boys and girls) 15 9 Current users 4 Add youth group 15-16* 22 11 2.5 13 4.4 15 8.8 2.1.6.1 Please indicate the tobacco products included in calculating prevalence for question 2.1.6: Cigarettes 4 Please provide data on either all current users or daily users only, whichever is available. 11

2.1.6.2 Please indicate the year and source of the data used to answer question 2.1.6: *ESPAD Survey, 2011 http://www.espad.org/uploads/espad_reports/2011/full20report20-20supplement20to20the20201120espad20report20-20web.pdf 2010 HBSC study https://ehealth.gov.mt/download.aspx?id=9500 2.1.6.3 Please provide the definition of current smoking/tobacco use used to answer question 2.1.6 in the space below. The question used in the ESPAD study asked 'How frequently have you smoked cigarettes during the LAST 30 DAYS? Data from the HBSC study looks at cigarette use in the last week. 2.1.6.4 Please provide a brief explanation of the trend in tobacco use by young persons in the past two years or since submission of your last report. ESPAD study - Reduction in overall smoking prevalence by 4 since last data collection in 2007. HBSC Increase in smoking amongst boys 11 and 13 years old and decrease amongst 15 year old boys. Decrease amongst girls in all ages. This is compared to last HBSC collection 2005/2006 2.2 EXPOSURE TO TOBACCO SMOKE 2.2 EXPOSURE TO TOBACCO SMOKE 2.2.1 Do you have any data on exposure to tobacco smoke in your population? 2.2.2 If you answered to question 2.2.1, please provide details in the space below (e.g. exposure by gender, at home, in the workplace, on public transport). Exposure by gender and age in the home, workplace and public transport 2.2.3 Please indicate the year and source of the data used to answer question 2.2.1: 2008, European Health Interview Survey 2.3 TOBACCO-RELATED MORTALITY 2.3 TOBACCO-RELATED MORTALITY 2.3.1 Do you have information on tobacco-related mortality in your population? 2.3.2 If you answered to question 2.3.1, what is the estimated total number of deaths attributable to tobacco use in your population? 439.5 2.3.3 If available, please provide any additional information on mortality attributable to tobacco use (e.g. lung cancer, cardiovascular diseases) in your jurisdiction. Cancer of Trachea/Bronchus/Lung ; Chronic Bronchitis/Emphysema; Ischemic Heart Disease SDR (ESP) per 100,000 available for 2012 12

2.3.4 Please indicate the year and source of the data used to answer questions 2.3.2 and 2.3.3, and please submit a copy of the study you refer to: https://ehealth.gov.mt/healthportal/chief_medical_officer/healthinfor_research/reg istries/deaths.aspx The 2012 Annual Mortality Report can be downloaded from this page 2.4 TOBACCO-RELATED COSTS 2.4 TOBACCO-RELATED COSTS 2.4.1 Do you have information on the economic burden of tobacco use in your population, e.g. the overall cost of tobacco use imposed on your society? 2.4.2 If you answered to question 2.4.1, please provide details (e.g. direct (health care-related) and indirect costs and, if possible, the method used to estimate these costs). 2.4.3 Please indicate the year and source of the data used to answer question 2.4.2, and please submit a copy of the study you refer to: 2.5 SUPPLY OF TOBACCO AND TOBACCO PRODUCTS 2.5 SUPPLY OF TOBACCO AND TOBACCO PRODUCTS (with reference to Articles 6.2(b), 20.4(c), and 15.5) 2.5.1 Licit supply of tobacco products Product Unit (e.g. pieces, tonnes) Domestic production Retail sales Exports Imports 13

Smoking tobacco products Add product Cigars piec es 2011 861,845 pieces 2011 861,845 pieces Cigars pieces 2012 816,563 pieces 2012 816,563 pieces Cigars pieces 2013 816,563 pieces 2013 732,335 pieces Pipe Tobacco produced Pipe Tobacco produced Pipe Tobacco produced kgs 2011 417.3kg kgs 2012 393.67kg kgs 2013 382.32kg 2011 417.3kg 2012 393.67kg 2013 382.32kgs Smokeless tobacco products Add product Other tobacco products Add product Tobacco Leaves 2.5.2 Please provide information on the volumes of duty-free sales (e.g. product, unit, quantity), if available. 2.5.3 Please indicate the year and source of the data used to answer questions 2.5.1 and 2.5.2: Data from Customs for years 2011, 2012, 2013. cigarettes are produced in Malta. 14

15

2.6 SEIZURES OF ILLICIT TOBACCO PRODUCTS 2.6 SEIZURES OF ILLICIT TOBACCO PRODUCTS (with reference to Article 15.5) 2.6.1 Year Product Unit (e.g. millions Quantity seized of pieces) Smoking tobacco products 2011 2011 Cigarettes HRT pieces kilos 4,500,000 3 Add row Smokeless tobacco products Add row Other tobacco products Add row 2012 Cigarettes pieces 26,800,000 2011 Snus / Skruf kilos 6.3 2012 Snus / Skruf kilos 16.76 2013 Snus / Skruf kilos 4 2011 Water pipe kilos 73.5 2012 Water pipe kilos 58.86 2013 Water pipe kilos 21.6 2.6.2 Do you have any information on the percentage of illicit tobacco products on the national tobacco market? 2.6.3 If you answered to question 2.6.2, what percentage of the national tobacco market do illicit tobacco products constitute? 2.6.4 If you answered to question 2.6.3 and you have information available, what is the trend over the past two years or since submission of your last report in the percentage of illicit tobacco products in relation to the national tobacco market? 2.6.5 Please provide any further information on illicit tobacco products. The most significant seizures were made at the Malta Freeport - transit shipments. A reasonable percentage of the cigarettes seized were counterfeit. It has been noted that illicit trafficking of tobacco smuggling is being noticed at mail/courier services. Cigarettes are being purchased on the Internet. 2.6.6 Please indicate the source of the data used to answer questions in section 2.6: Malta Customs Department. 2.7 TOBACCO-GROWING 2.7 TOBACCO-GROWING 2.7.1 Is there any tobacco-growing in your jurisdiction? t applicable 2.7.2 If you answered to question 2.7.1, please provide information on the number of workers involved in tobacco-growing. If available, please provide this figure 16

broken down by gender. 2.7.3 Please provide, if available, the share of the value of tobacco leaf production in the national gross domestic product. 2.7.4 Please indicate the year and source of the data used to answer questions in section 2.7: 2.8 TAXATION OF TOBACCO PRODUCTS 2.8 TAXATION OF TOBACCO PRODUCTS (with reference to Articles 6.2(a) and 6.3) 2.8.1 What proportion of the retail price of the most popular price category of tobacco product consists of taxes (e.g. sum of excise, sales and import duties (if applicable) and value added tax/goods and services tax (VAT/GST))? The Excise Section of the Customs Department is familiar only with the Retail Price of CIGARETTES, since it is necessary to calculate the Excise Duty. Years 2011, 2012, 2013 01/01/2011-14/11/2011 - Excise Duty & VAT as a proportion to Retail Price of cigarettes ( 210/1000) of MPPC = 75.58 15/11/2011-28/02/2013 - Excise Duty & VAT as a proportion to Retail Price of cigarettes ( 220/1000) of MPPC = 75.25 01/03/2013-08/04/2013 - Excise Duty & VAT as a proportion to Retail Price of cigarettes ( 225/1000) of MPPC = 74.46 09/04/2013-04/11/2013 - Excise Duty & VAT as a proportion to Retail Price of cigarettes ( 235/1000) of MPPC = 75.36 05/11/2013-31/12/2013 - Excise Duty & VAT as a proportion to Retail Price of cigarettes ( 250/1000) of MPPC = 75.26 2.8.2 How are the excise taxes levied (what types of taxes are levied)? Specific tax only On cigars & cigarillos (per 1000 units) On Fine Cut Tobacco (per Kg.) On Pipe Tobacco (per Kg.) Ad valorem tax only Combination of specific and ad valorem taxes On cigarettes More complex structure (please explain: ) 17

2.8.3 If available, please provide details on the rates of taxation for tobacco products at all levels of Government and be as specific as possible (specify the type of tax, e.g. VAT, sales, import duties) Smoking tobacco products Add product Product Type of tax Rate or amount Base of tax 5 Cigarettes EXCISE DUTY (Combination of specific and ad valorem) 01/01/2011-14/11/2011 47.0 of the RP plus 28 per 1000 cigarettes but not less than 120.50 per 1000 cigarettes. 15/11/2011-08/04/2013 25.0 of the RP plus 77 per 1000 cigarettes but not less than 127.50 per 1000 cigarettes. Retail Price Cigarettes Cigarettes Cigarettes Cigars & Cigarillos EXCISE DUTY (Combination of specific and ad valorem) VAT (ad valorem) Import Duty (ad valorem) EXCISE DUTY (Specific) 09/04/2013-04/11/2013 25.0 of the RP plus 82.50 per 1000 cigarettes but not less than 135 per 1000 cigarettes. 05/11/2013-31/12/2013 25.0 of the RP plus 87.50 per 1000 cigarettes but not less than 142.50 per 1000 cigarettes. Retail Price 2011, 2012, 2013 18 value 2011, 2012, 2013 As per EU Taric 01/01/2011-14/11/2011 16.90 15/11/2011-08/04/2013 value 1000 units 5 The base of the tax should clearly indicate the tax rate or amount the tax is based on. If the tax is expressed as a percentage (e.g. ad valorem tax), the base of the tax is the actual value of the good that is taxed; for example, 45 of the manufacturer s price, 30 of the retail price. In this case the base is the manufacturer s price or retail price. If the tax is expressed as an amount (e.g. specific tax), the base of the tax is the volume (number of pieces or by weight) of goods that is taxed. For example, if a tax is US$ 5 per 100 cigarettes, the amount of tax is US$ 5 and the base of the tax is 100 cigarettes. 18

18.34 09/04/2013-04/11/2013 19.81 05/11/2013-31/12/2013 21.65 Smoking tobacco products Cigars & Cigarillos Cigars & Cigarillos VAT (ad valorem) Import Duty (ad valorem) 2011, 2012, 2013 18 Value 2011, 2012, 2013 As per EU Taric Value 01/01/2011-14/11/2011 75.40 Fine Cut Tobacco EXCISE DUTY (Specific) 15/11/2011-08/04/2013 81.81 09/04/2013-04/11/2013 88.36 Kg. 05/11/2013-31/12/2013 96.58 Fine Cut Tobacco Fine Cut Tobacco VAT (ad valorem) Import Duty (ad valorem) 2011, 2012, 2013 18 Value 2011, 2012, 2013 As per EU Taric 01/01/2011-14/11/2011 23.96 Value PipeTobacco EXCISE DUTY (Specific) 15/11/2011-08/04/2013 26.00 09/04/2013-04/11/2013 28.08 Kg. 05/11/2013-31/12/2013 30.69 Pipe Tobacco VAT (ad 2011, 2012, 2013 18 value 19

valorem) Pipe Tobacco Import Duty (ad valorem) 2011, 2012, 2013 As per EU Taric Value 2.8.4 Smokeless tobacco products Add product Other tobacco products Add product 2.8.5 Do you earmark any percentage of your taxation income for funding any national plan or strategy on tobacco control in your jurisdiction? (In reference to Article 26) 2.8.6 If you answered to question 2.8.5, please provide details in the space below 2.8.7 Please indicate the year and source of the data used to answer questions 2.8.1 to 2.8.6: Years 2011, 2012 and 2013. Customs Department 2.9 PRICE OF TOBACCO PRODUCTS 2.9 PRICE OF TOBACCO PRODUCTS (with reference to Article 6.2(a)) 2.9.1 Please provide the retail prices of the three most widely sold brands of domestic and imported tobacco products at the most widely used point of sale in your capital city. Domestic Smoking tobacco products Most widely sold brand Smokeless tobacco products Other tobacco products Number of units or amount per package Retail price 20

Imported Cigarettes- 2011 1000 210 Rothmans KS 190 Royals KS 165 Pall Mall KS Cigarettes- 2012 1000 220 Rothmans KS 200 - Royals KS 175 - Pall Mall KS Cigarettes- 2013 1000 235 - Rothmans 190- Pall Mall KS 215- Royals KS 2.9.2 Please indicate the year and source of the data used to answer question 2.9.1. Years 2011, 2012 and 2013. Customs Department 2.9.3 Please provide the currency used to complete the Rate or amount section of question 2.8.3 and the Retail price section of question 2.9.1. If known, please provide the exchange rate of this currency to US dollars as well as the date of this exchange rate. 21

Euro 2.9.4 Please briefly describe the trend in the prices of tobacco products in the past two years or since submission of your last report in your jurisdiction. Retail Prices of cigarettes have increased during 2011 2012 and 2013. 22

3. LEGISLATION, REGULATION AND POLICIES 3.1 GENERAL OBLIGATIONS 3.1 Article GENERAL OBLIGATIONS (with reference to Article 5) 3.1.1 5 General obligations 3.1.1.1 5.1 Have you developed and implemented comprehensive multisectoral national tobacco control strategies, plans and programmes in accordance with the Convention? 3.1.1.2 If you answered to question 3.1.1.1, have you partially developed and implemented tobacco control strategies by including tobacco control in national health, public health or health promotion strategies, plans and programmes? 3.1.1.3 If you answered to question 3.1.1.2, is any aspect of tobacco control that is referred to in the Convention included in any national strategy, plan or programme? 3.1.1.4 5.2(a) Have you established or reinforced and financed a focal point for tobacco control a tobacco control unit a national coordinating mechanism for tobacco control 3.1.1.5 If you answered to any of the questions under 3.1.1.4, please provide details (e.g. the nature of the national coordinating mechanism, the institution to which the focal point for tobacco control or the tobacco control unit belongs). Environmental Health Directorate Tobacco Control Act http://www.justiceservices.gov.mt/downloaddocument.aspx?app=lom&itemid=87 91&l=1 3.1.1.6 Please provide a brief description of the progress made in implementing Article 5.1 and 5.2 (General obligations) in the past two years or since submission of your last report. 23

A smoking ban has been introduced in public places including playgrounds. Legislation regarding the mandatory use of colour pictorials as well as health warnings on all kinds of tobacco packages has been enacted. Links below- http://justiceservices.gov.mt/downloaddocument.aspx?app=lp&itemid=21129&l=1 http://justiceservices.gov.mt/downloaddocument.aspx?app=lp&itemid=22737&l=1 http://justiceservices.gov.mt/downloaddocument.aspx?app=lp&itemid=21010&l=1 3.1.1.7 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. 24

3.1.2 5.3 Protection of public health policies with respect to tobacco control from commercial and other vested interests of the tobacco industry (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.1.2.1 protecting public health policies with respect to tobacco control from commercial and other vested interests of the tobacco industry? wide range of information on tobacco industry activities relevant to the objectives of the Convention, such as in a public repository? 3.1.2.2 ensuring that the public has access, in accordance with Article 12(c), to a 3.1.2.3 If you answered to any of the questions under 3.1.2.1 or 3.1.2.2, please provide details in the space below. Administrative policies and work ethics prohibit any conflict. 3.1.2.4 Please provide a brief description of the progress made in implementing Article 5.3 in the past two years or since submission of your last report. 3.1.2.5 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES Please use the space below to provide additional information regarding use of the Guidelines for implementation of Article 5.3 of the WHO FCTC in your jurisdiction (please refer to the section on Article 5.3 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.1.2.6 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. 25

3.2 MEASURES RELATING TO THE REDUCTION OF DEMAND FOR TOBACCO 3.2 Article MEASURES RELATING TO THE REDUCTION OF DEMAND FOR TOBACCO (with reference to Articles 6 14) 3.2.1 6 Price and tax measures to reduce the demand for tobacco (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.2.1.1 6.2(a) tax policies and, where appropriate, price policies on tobacco products so as to contribute to the health objectives aimed at reducing tobacco consumption? 3.2.1.2 6.2(b) prohibiting or restricting, as appropriate, sales to international travellers of tax- and duty-free tobacco products? 3.2.1.3 prohibiting or restricting, as appropriate, imports by international travellers of tax- and duty-free tobacco products? 3.2.1.4 Please provide a brief description of the progress made in implementing Article 6 (Price and tax measures to reduce the demand for tobacco) in the past two years or since submission of your last report. Increase in tax measures over the last two years. 3.2.1.5 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. 26

3.2.2 8.2 Protection from exposure to tobacco smoke (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.2.2.1 banning tobacco smoking in indoor workplaces, public transport, indoor public places and, as appropriate, other public places? 3.2.2.2 If you answered "" to question 3.2.2.1, what is the type/nature of the measure providing for the ban? national law subnational law(s) administrative and executive orders voluntary agreements 3.2.2.3 other measures (please specify: ) Please provide a brief explanation of the type/nature and content of the measures providing for the ban. Links to most recent legislation on smoking ban in playgrounds and the need for authorisation by health authorities of designated smoking rooms. http://justiceservices.gov.mt/downloaddocument.aspx?app=lp&itemid=21129&l= 1 http://justiceservices.gov.mt/downloaddocument.aspx?app=lp&itemid=22737&l= 1 3.2.2.4 If you answered to any options in 3.2.2.2, do any of these measures provide for a mechanism/ infrastructure for enforcement? 3.2.2.5 If you answered "" to question 3.2.2.4 please provide details of this system. Enforcement includes legal proceedings and penalties. 27

3.2.2.6 If you answered to question 3.2.2.1, please specify the settings and extent/comprehensiveness of measures applied in indoor workplaces, public transport, indoor public places and, as appropriate, other public places. Complete Partial ne Indoor workplaces: government buildings health-care facilities educational facilities 1 universities private workplaces other (please specify: ) Public transport: airplanes trains t applicable, no trains in Malta ferries ground public transport (buses, trolleybuses, trams) motor vehicles used as places of work (taxis, ambulances, delivery vehicles) private vehicles other (please specify: ) 1 except universities 28

Indoor public places: cultural facilities shopping malls pubs and bars nightclubs restaurants other (please specify: ) 3.2.2.7 Please provide a brief summary of complete and partial measures, with specific details of the partial measures that have been implemented. Banning tobacco smoking in indoor workplaces Total ban except in designated rooms in Casinos. Banning tobacco smoking in public transport Total Banning tobacco smoking in indoor public places Total 3.2.2.8 Please provide a brief description of the progress made in implementing Article 8 (Protection from exposure to tobacco smoke) in the past two years or since submission of your last report. Introduction of ban in enclosed areas 3.2.2.9 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES Please use the space below to provide additional information regarding use of the Guidelines for implementation of Article 8 of the WHO FCTC in your jurisdiction (please refer to the section on Article 8 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.2.2.10 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. Link to legislation re designated smoking rooms in Casino. http://www.justiceservices.gov.mt/downloaddocument.aspx?app=lp&itemid=2539 6&l=1 29

3.2.3 9 Regulation of the contents of tobacco products (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.2.3.1 testing and measuring the contents of tobacco products? 3.2.3.2 testing and measuring the emissions of tobacco products? 3.2.3.3 regulating the contents of tobacco products? 3.2.3.4 regulating the emissions of tobacco products? 3.2.3.5 Please provide a brief description of the progress made in implementing Article 9 (Regulation of the contents of tobacco products) in the past two years or since submission of your last report. Legislation to label, monitor and sampling the contents 3.2.3.6 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES Please use the space below to provide additional information regarding use of the Guidelines for implementation of Articles 9 and 10 of the WHO FCTC in your jurisdiction (please refer to the section on Article 9 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.2.3.7 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. 30

3.2.4 10 Regulation of tobacco product disclosures (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.2.4.1 requiring manufacturers or importers of tobacco products to disclose to Government authorities information about the: contents of tobacco products? emissions of tobacco products? 3.2.4.2 requiring public disclosure of information about the: contents of tobacco products? emissions of tobacco products? 3.2.4.3 Please provide a brief description of the progress made in implementing Article 10 (Regulation of tobacco product disclosures) in the past two years or since submission of your last report. Legislation implemented 3.2.4.4 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES Please use the space below to provide additional information regarding use of the Guidelines for implementation of Articles 9 and 10 of the WHO FCTC in your jurisdiction (please refer to the section on Article 10 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.2.4.5 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. 31

3.2.5 11 Packaging and labelling of tobacco products (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.2.5.1 11 requiring that packaging, individual cigarettes or other tobacco products do not carry advertising or promotion? 3.2.5.2 11.1(a) requiring that packaging and labelling do not promote a product by any means that are false, misleading, deceptive or likely to create an erroneous impression about its characteristics, health effects, hazards or emissions? 3.2.5.3 11.1(b) requiring that each unit packet and package of tobacco products and any outside packaging and labelling of such products carry health warnings describing the harmful effects of tobacco use? 3.2.5.4 11.1(b)(i) ensuring that the health warnings are approved by the competent national authority? 3.2.5.5 11.1(b)(ii) ensuring that the health warnings are rotated? 3.2.5.6 11.1(b)(iii) ensuring that the health warnings are clear, visible and legible? 3.2.5.7 11.1(b)(iii) If you answered "" to question 3.2.5.6, does your law mandate, as a minimum, a style, size and colour of font to render the warning clear, visible and legible? 3.2.5.8 11.1(b)(iv) ensuring that the health warnings occupy no less than 30 of the principal display areas? 3.2.5.9 ensuring that the health warnings occupy 50 or more of the principal display areas? 3.2.5.10 11.1(b)(v) ensuring that health warnings are in the form of, or include, pictures or pictograms? 32

3.2.5.11 If you answered to question 3.2.5.10, does the Government own the copyright to these pictures and pictograms? 3.2.5.12 If you answered to question 3.2.5.10, would you grant a nonexclusive and royalty-free licence for the use of health warnings developed in your jurisdiction with other Parties? 3.2.5.13 11.2 requiring that each unit packet and package of tobacco products and any outside packaging and labelling of such products contain information on relevant: constituents of tobacco products emissions of tobacco products 3.2.5.14 11.3 requiring that the warnings and other textual information appear on each unit packet and package and on any outside packaging and labelling in the principal language or languages of the country? 3.2.5.15 Please provide a brief description of the progress made in implementing Article 11 (Packaging and labelling of tobacco products) in the past two years or since submission of your last report. In line with EU legislation. Royalty rights of pictorials used belong to the Commission of the European Union. 3.2.5.16 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES Please use the space below to provide additional information regarding use of the Guidelines for implementation of Article 11 of the WHO FCTC in your jurisdiction (please refer to the section on Article 11 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.2.5.17 If you have any other relevant information pertaining to or not covered in this section, please provide details in the space below. 33

3.2.6 12 Education, communication, training and public awareness (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.2.6.1 12(a) educational and public awareness programmes? (Please refer to programmes implemented since submission of your two-year report.) 3.2.6.2 If you answered to question 3.2.6.1, to whom are these programmes targeted? adults or the general public children and young people men women pregnant women ethnic groups other (please specify: ) 3.2.6.3 If you answered to question 3.2.6.1, do you reflect the following key differences among targeted population groups in educational and public awareness programmes? age gender educational background cultural background socioeconomic status other (please specify: ) 34

3.2.6.4 12(b) If you answered to question 3.2.6.1, do these educational and public awareness programmes cover: health risks of tobacco consumption? health risks of exposure to tobacco smoke? benefits of the cessation of tobacco use and tobacco-free lifestyles? 12(f) adverse economic consequences of - tobacco production? - tobacco consumption? adverse environmental consequences of - tobacco production? - tobacco consumption? 3.2.6.5 12(e) awareness and participation of the following agencies and organizations in development and implementation of intersectoral programmes and strategies for tobacco control: public agencies? nongovernmental organizations not affiliated with the tobacco industry? private organizations? other (please specify: )? 3.2.6.6 12 Are the elaboration, management and implementation of communication, education, training and public awareness programmes guided by research and do they undergo pre-testing, monitoring and evaluation? 3.2.6.7 12(d) Are appropriate and special training or sensitization and awareness programmes on tobacco control addressed to: health workers? community workers? social workers? media professionals? 35

educators? decision-makers? administrators? other (please specify: )? 3. 2.6.8 Please provide a brief description of the progress made in implementing Article 12 (Education, communication, training and public awareness) in the past two years or since submission of your last report. The following initiatives were held by the Health Promotion and Disease Prevention Directorate within the Health Ministry and are still ongoing: o Raising awareness through initiatives in the community such as World Heart Day, World Tobacco Day in collaboration with other stakeholders, activities in middle and high school and Cycling Marathon in a Secondary School. o Training of facilitators/teachers o Continuation with dissemination of information during Personal and Social Development lessons o Distribution of leaflets on passive smoking during Physical Education classes 3.2.6.9 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES Please use the space below to provide additional information regarding use of the Guidelines for implementation of Article 12 of the WHO FCTC in your jurisdiction (please refer to the section on Article 12 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.2.6.10 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. 36

3.2.7 13 Tobacco advertising, promotion and sponsorship (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, any legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes: 3.2.7.1 13.2 instituting a comprehensive ban on all tobacco advertising, promotion and sponsorship? If you answered to question 3.2.7.1, please proceed to question 3.2.7.3. 3.2.7.2 If you answered to question 3.2.7.1, does your ban cover: display and visibility of tobacco products at points of sales? the domestic Internet? the global Internet? brand stretching and/or brand sharing? product placement as a means of advertising or promotion? the depiction of tobacco or tobacco use in entertainment media products? tobacco sponsorship of international events or activities and/or participants therein? contributions from tobacco companies to any other entity for socially responsible causes and/or any other activities implemented under the umbrella of corporate social responsibility by the tobacco industry? cross-border advertising, promotion and sponsorship originating from your territory? 37

13.7 the same forms of cross-border advertising, promotion and sponsorship entering your territory for which domestic regulation apply? Please proceed to question 3.2.7.12. 3.2.7.3 13.2 If you answered "" to question 3.2.7.1. are you precluded by your constitution or constitutional principles from undertaking a comprehensive ban on tobacco advertising, promotion and sponsorship? 3.2.7.4 13.3 applying restrictions on all tobacco advertising, promotion and sponsorship? 3.2.7.5 13.3 applying restrictions on cross-border advertising, promotion and sponsorship originating from your territory with cross-border effects? 3.2.7.6 13.4(a) prohibiting those forms of tobacco advertising, promotion and sponsorship that promote a tobacco product by any means that are false, misleading, deceptive or likely to create an erroneous impression about its characteristics, health effects, hazards or emissions? 3.2.7.7 13.4(b) requiring that health or other appropriate warnings or messages accompany all tobacco advertising, promotion and sponsorship? 3.2.7.8 13.4(c) restricting the use of direct or indirect incentives that encourage the purchase of tobacco products by the public? 3.2.7.9 13.4(d) requiring the disclosure to relevant Government authorities of expenditures by the tobacco industry on advertising, promotion and sponsorship not yet prohibited? 38

3.2.7.10 13.4(e) restricting tobacco advertising, promotion and sponsorship on: radio? television? print media? the domestic Internet? the global Internet? other media (please specify: )? 3.2.7.11 13.4(f) restricting tobacco sponsorship of: international events and activities? participants therein? Whether you answered or to question 3.2.7.1, are you: 3.2.7.12 13.6 cooperating with other Parties in the development of technologies and other means necessary to facilitate the elimination of cross-border advertising? 3.2.7.13 13.7 imposing penalties for cross-border advertising equal to those applicable to domestic advertising, promotion and sponsorship originating from your territory in accordance with national law? 3.2.7.14 Please provide a brief description of the progress made in implementing Article 13 (Tobacco advertising, promotion and sponsorship) in the past two years or since submission of your last report. Legislation no advert/promotion is allowed by legislation 3.2.7.15 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES Please use the space below to provide additional information regarding use of the Guidelines for implementation of Article 13 of the WHO FCTC in your jurisdiction (please refer to the section on Article 13 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.2.7.16 If you have any other relevant information pertaining to but not covered in this 39

section, please provide details in the space below. 40

3.2.8 14 Demand reduction measures concerning tobacco dependence and cessation (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.2.8.1 14.1 developing and disseminating appropriate, comprehensive and integrated guidelines based on scientific evidence and best practices? 3.2.8.2 14.1 programmes to promote cessation of tobacco use, including: media campaigns emphasizing the importance of quitting? programmes specially designed for: o underage girls and young women o women o pregnant women telephone quitlines local events, such as activities related to World Tobacco Day or National Smoking Day, if appropriate? other (please specify: )? 3.2.8.3 14.2(a) design and implementation of programmes aimed at promoting the cessation of tobacco use, in such locations as: educational institutions? health-care facilities? workplaces? sporting environments? 41

other (please specify: )? 3.2.8.4 14.2(b) inclusion of diagnosis and treatment of tobacco dependence and counselling services for cessation of tobacco use in national programmes, plans and strategies for: tobacco control? health? education? 3.2.8.5 inclusion of programmes on the diagnosis and treatment of tobacco dependence in your health-care system? 3.2.8.6 14.2(b) If you answered to question 3.2.8.5, which structures in your health-care system provide programmes for the diagnosis and treatment of tobacco dependence? primary health care secondary and tertiary health care specialist health-care systems (please specify: ) specialized centres for cessation counselling and treatment of tobacco dependence rehabilitation centres other (please specify: ) 3.2.8.7 14.2(b) If you answered to question 3.2.8.5, are the services provided in these settings covered by public funding or reimbursement schemes? primary health care Fully Partially ne secondary and tertiary health care Fully Partially ne specialist health-care systems (please specify: ) Fully Partially ne 42

specialized centres for cessation counselling and treatment of tobacco dependence Fully Partially ne rehabilitation centres Fully Partially ne other (please specify: ) Fully Partially ne 3.2.8.8 14.2(b) If you answered to question 3.2.8.5, which health and other professionals are involved in programmes offering treatment for tobacco dependence and counselling services? Health professionals including: physicians dentists family doctors practitioners of traditional medicine other medical professionals (please specify: ) nurses midwives pharmacists Community workers Social workers Others (please specify: ) 3.2.8.9 14.2(c) training on tobacco dependence treatment incorporated into the curricula of health professional training at pre- and post-qualification levels at the following schools: medical? dental? nursing? pharmacy? 43

other (please specify: )? 3.2.8.10 14.2(d) facilitating accessibility and/or affordability of pharmaceutical products for the treatment of tobacco dependence? 3.2.8.11 14.2(d) If you answered to question 3.2.8.10, where and how can these products be legally purchased in your country? From local pharmacies on presentation of a medical prescription 3.2.8.12 14.2(d) If you answered to question 3.2.8.10, which pharmaceutical products are legally available for the treatment of tobacco dependence in your jurisdiction? nicotine replacement therapy bupropion varenicline other (please specify: ) 3.2.8.13 14.2(d) If you answered to question 3.2.8.10, are the costs of these products covered by public funding or reimbursement? nicotine replacement therapy Fully Partially ne bupropion Fully Partially ne varenicline Fully Partially ne other (please specify: ) Fully Partially ne 3.2.8.14 Please provide a brief description of the progress made in implementing Article 14 (Demand reduction measures concerning tobacco dependence and cessation) in the past two years or since submission of your last report. o Adverts on TV o Training of facilitators at the main acute hospital - Mater Dei State Hospital (MDH) o Seminar on role of the Health Care Professional at MDH o Designing and implementing smoking cessation programmes for Health Care Professionals in their work place o Committee on Smoking and Health for the eventuality of a Smoke free State Hospital 3.2.8.15 USE OF THE GUIDELINES ADOPTED BY THE CONFERENCE OF THE PARTIES 44

Please use the space below to provide additional information regarding use of the Guidelines for implementation of Article 14 of the WHO FCTC in your jurisdiction (please refer to the section on Article 14 of the step-by-step instructions document when responding to this question). Alternatively, you may wish to provide detailed information through the additional questionnaire on the use of guidelines. Response to this section or to the additional questionnaire is voluntary. 3.2.8.16 If you have any other relevant information pertaining to but not covered in this section, please provide details in the space below. 45

3.3 MEASURES RELATING TO THE REDUCTION OF THE SUPPLY OF TOBACCO 3.3 Article MEASURES RELATING TO THE REDUCTION OF THE SUPPLY OF TOBACCO (with reference to Articles 15 17) 3.3.1 15 Illicit trade in tobacco products (Please check or. For affirmative answers, please provide a brief summary in the space provided at the end of the section and attach the relevant documentation. Please provide documentation, if available, in one of the six official languages.) Have you adopted and implemented, where appropriate, legislative, executive, administrative or other measures or have you implemented, where appropriate, programmes on any of the following: 3.3.1.1 15.2 requiring marking of all unit packets and packages of tobacco products and any outside packaging of such products to assist in determining the origin of the product? 3.3.1.2 15.2(a) requiring marking of all unit packets and packages of tobacco products and any outside packaging of such products to assist in determining whether the product is legally sold on the domestic market? 3.3.1.3 15.2(a) requiring that unit packets and packages of tobacco products for retail and wholesale use that are sold on the domestic market carry the statement: Sales only allowed in or carry any other effective marking indicating the final destination of the product? 3.3.1.4 15.2(b) developing a practical tracking and tracing regime that would further secure the distribution system and assist in the investigation of illicit trade? 3.3.1.5 15.3 requiring that marking is presented in legible form or appears in the principal language and/or languages of the country? 3.3.1.6 15.4(a) requiring the monitoring and collection of data on cross-border trade in tobacco products, including illicit trade? 46